Residency · Residency · Urology
Evaluation of Female Stress Urinary Incontinence
Definitions
Stress urinary incontinence (SUI) is defined as the involuntary leakage of urine that occurs during physical effort, exertion, sneezing, or coughing. Urgency urinary incontinence (UUI) involves involuntary leakage that is accompanied by or immediately preceded by a sudden, compelling urge to urinate. Mixed urinary incontinence (MUI) represents a combination of both SUI and UUI, and management typically targets the component that is most predominant or bothersome to the patient. Overflow incontinence results from bladder overdistension due to incomplete emptying, leading to leakage. Functional incontinence arises not from lower urinary tract dysfunction but from cognitive or mobility impairments that prevent timely toileting.
Epidemiology
Stress urinary incontinence affects approximately 15-35% of adult women, with its prevalence increasing with advancing age, parity, and obesity. Among women younger than 60 years, SUI is the most common type of urinary incontinence. After the age of 60, urgency urinary incontinence becomes more prevalent. Urinary incontinence significantly impacts quality of life, social functioning, and mental health, underscoring the importance of accurate diagnosis and effective management.
Pathophysiology of SUI
The pathophysiology of SUI primarily involves two mechanisms. The first is urethral hypermobility, which occurs when weakening of the pelvic floor support structures causes the urethra to descend rotationally during a Valsalva maneuver. This descent results in inadequate pressure transmission to the urethra relative to the bladder, allowing urine leakage. The second mechanism is intrinsic sphincter deficiency (ISD), where the urethral sphincter itself is weakened, often described as a fixed, pipe-stem urethra. ISD frequently coexists with urethral hypermobility and is associated with risk factors such as prior anti-incontinence surgery, radiation therapy, neurologic injury, and aging. Objective measures include a Valsalva leak point pressure (VLPP) less than 60 cmH2O or a maximum urethral closure pressure (MUCP) below 20 cmH2O. Most patients exhibit a combination of both mechanisms contributing to their symptoms.
Risk Factors
Several risk factors predispose women to SUI. Vaginal delivery, especially when complicated by forceps use, prolonged labor, or delivery of a large baby, increases risk. Multiparity further elevates this risk. Obesity, defined as a body mass index (BMI) greater than 30, is a significant contributor. Aging and menopause lead to tissue atrophy, weakening pelvic support. Prior pelvic surgeries, chronic constipation or straining, chronic cough from conditions like COPD or smoking, and connective tissue disorders also increase susceptibility.
<image>Anatomic diagram comparing normal urethral support with pubourethral ligament and endopelvic fascia integrity versus stress incontinence with urethral hypermobility and deficient support</image>
Clinical Evaluation
History
A thorough history is essential to characterize the nature of urinary leakage. It is important to identify the provoking factors, such as coughing, sneezing, exercise, or positional changes, and to determine whether there is an urgency component. Additional details include frequency of urination, nocturia, sensations of incomplete emptying, and pad usage including the number and type of pads. The duration and progression of symptoms should be noted. Fluid intake habits, particularly caffeine and alcohol consumption and overall volume, are relevant. Obstetric history should include parity, mode of delivery, birth weight, and any instrumentation used. Surgical history must document prior anti-incontinence procedures, pelvic surgeries, and hysterectomies. Medication review should consider drugs that may contribute to symptoms, such as diuretics, alpha-blockers, and ACE inhibitors that can cause cough. Neurologic symptoms like numbness, weakness, or bowel dysfunction should be assessed. Finally, the impact on quality of life should be evaluated using validated questionnaires.
Validated Questionnaires
Several validated questionnaires assist in symptom assessment and impact evaluation. The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) measures symptom severity and bother. The Urogenital Distress Inventory (UDI-6) assesses symptom burden, while the Incontinence Impact Questionnaire (IIQ-7) evaluates quality of life impact. The Overactive Bladder Questionnaire (OAB-q) is useful for assessing symptoms related to overactive bladder.
Physical Examination
Physical examination begins with an abdominal assessment to detect a palpable bladder suggestive of retention, masses, and to evaluate BMI. The pelvic exam assesses vaginal atrophy, pelvic organ prolapse using the POP-Q staging system, urethral mobility, and pelvic floor muscle strength graded on the modified Oxford scale from 0 to 5. The cough stress test is performed with the bladder filled to 200-300 mL, observing for leakage during coughing in both supine and standing positions. A positive test with a full bladder in the supine position confirms SUI, while standing may increase sensitivity. Immediate leakage with cough indicates SUI, whereas delayed leakage suggests an urgency component. The Q-tip test involves inserting a lubricated cotton swab into the urethra up to the bladder neck and measuring the angle at rest and during straining; a straining angle greater than 30 degrees from horizontal indicates urethral hypermobility. Although less commonly performed now, clinical observation often suffices. The Bonney or Marshall test involves elevating the bladder neck with fingers during coughing; cessation of leakage supports hypermobility but is not routinely used due to subjectivity.
Voiding Diary (Bladder Diary)
A voiding diary of at least three days is recommended to record fluid intake, voiding times, volumes, leakage episodes, pad changes, and urgency episodes. This tool helps differentiate between SUI, UUI, and MUI, and can identify polyuria, excessive fluid intake, or nocturnal polyuria.
Laboratory
Laboratory evaluation includes urinalysis to exclude urinary tract infection or hematuria. Post-void residual (PVR) volume is measured by ultrasound or catheterization to rule out overflow incontinence, with normal PVR defined as less than 100-150 mL. Urine culture is indicated if infection is suspected.
<image>Clinical demonstration of the cough stress test in the supine position with a comfortably full bladder, and the Q-tip test measuring urethral angle at rest and strain</image>
Pad Testing
Pad testing provides an objective quantification of urine loss. The 1-hour pad test, standardized by the International Continence Society (ICS), involves a pre-weighed pad, standardized fluid intake, and a defined activity protocol; a weight gain exceeding 1 gram is considered positive. The 24-hour pad test better reflects daily activity, with weight gains over 4 grams indicating mild, over 8 grams moderate, and over 36 grams severe incontinence. Pad testing is useful in clinical trials, assessing surgical outcomes, and quantifying severity.
Urodynamics
When to Perform
Urodynamic studies are not required for uncomplicated SUI when a positive cough stress test is present and a sling procedure is planned. The American Urological Association (AUA) and Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) guidelines consider urodynamics optional in such cases. Indications for urodynamics include uncertain diagnosis due to mixed symptoms or unclear examination findings, failure of prior anti-incontinence surgery, suspicion of neurogenic bladder, significant pelvic organ prolapse that may mask SUI (occult SUI), symptoms that do not correlate with examination, and elevated PVR or suspected voiding dysfunction.
Components Relevant to SUI
Filling cystometry assesses bladder compliance, capacity, and detrusor overactivity. The Valsalva leak point pressure (VLPP) measures the abdominal pressure at which leakage occurs during Valsalva; values below 60 cmH2O suggest ISD, 60-90 cmH2O are indeterminate, and above 90 cmH2O indicate predominant hypermobility. Maximum urethral closure pressure (MUCP), measured by urethral pressure profilometry, below 20 cmH2O also suggests ISD. Pressure-flow studies evaluate for bladder outlet obstruction or detrusor underactivity. Videourodynamics combines fluoroscopy with pressure measurements to visualize anatomy during filling and voiding phases.
VALUE Trial (NEJM 2012)
The VALUE trial demonstrated that preoperative urodynamic testing in uncomplicated SUI did not improve surgical outcomes compared to office evaluation alone. This supports a selective rather than routine use of urodynamics in these patients.
Imaging
Pelvic ultrasound can assess post-void residual volume and pelvic anatomy but is not routinely required. Perineal or translabial ultrasound is emerging as a useful tool for evaluating urethral mobility and mesh position after sling procedures. Magnetic resonance imaging (MRI) of the pelvis is reserved for complex cases, suspected fistula, or neurologic evaluation. Voiding cystourethrogram (VCUG) is occasionally used for complex anatomy or fistula assessment.
<image>Urodynamic tracing showing demonstrable stress urinary incontinence with Valsalva maneuver during filling phase, with corresponding Valsalva leak point pressure measurement</image>
Differentiating SUI from Other Types
Stress urinary incontinence is characterized by leakage triggered by cough, sneeze, or exercise, typically involving small spurts of urine. Frequency and urgency are usually absent, nocturia is uncommon, and the cough stress test is positive. Urodynamics reveal stress leakage without detrusor overactivity. Urgency urinary incontinence, in contrast, involves leakage triggered by urgency or stimuli like running water, with larger volumes leaked, frequent urgency, common nocturia, a negative cough stress test, and detrusor overactivity on urodynamics. Mixed urinary incontinence presents with features of both types, with variable leakage volume, frequency, and test results.
Initial Conservative Management
Pelvic floor muscle training (PFMT), commonly known as Kegel exercises, is the first-line treatment for all women with SUI. Ideally supervised by a physiotherapist, a trial of at least three months is recommended before considering escalation. Improvement rates range from 50-70%. Weight loss is highly effective; a 5-10% reduction in body weight can decrease SUI episodes by approximately 50%, as demonstrated in the PRIDE study. Behavioral modifications include timed voiding, fluid management, and caffeine reduction. Vaginal pessaries or incontinence rings can provide mechanical support to the bladder neck and serve as alternatives to surgery. Topical estrogen therapy may improve mild SUI in postmenopausal women with vaginal atrophy, whereas systemic estrogen has been shown to potentially worsen SUI.
Clinical Pearls
A positive cough stress test performed in the office setting is sufficient to diagnose SUI in most cases, and urodynamics are not mandatory before sling surgery for uncomplicated SUI, as supported by the VALUE trial. It is essential to check post-void residual volume before attributing incontinence to SUI because overflow incontinence can mimic stress symptoms. In women with significant pelvic organ prolapse, testing for occult SUI by reducing the prolapse during the cough stress test using a pessary or speculum is important, as unmasked SUI may necessitate a concurrent anti-incontinence procedure. Weight loss is the most impactful lifestyle modification for SUI, with a 5-10% reduction in weight halving the number of incontinence episodes. Mixed urinary incontinence is common, and treatment should focus on the component that is most bothersome to the patient. Finally, the voiding diary remains one of the most underutilized yet valuable diagnostic tools, providing objective data on frequency, volume, and leakage patterns.
References
- AUA/SUFU Guideline on Stress Urinary Incontinence in Women, 2017 (amended 2023)
- EAU Guidelines on Urinary Incontinence, 2024 Update
- Nager CW, et al. "A randomized trial of urodynamic testing before stress-incontinence surgery" (VALUE Trial). NEJM. 2012;366(21):1987-1997.
- Subak LL, et al. "Weight loss to treat urinary incontinence" (PRIDE Trial). NEJM. 2009;360(5):481-490.
- Dumoulin C, et al. "Pelvic floor muscle training for urinary incontinence." Cochrane Database Syst Rev. 2018.
- Campbell-Walsh-Wein Urology, 12th Edition, Chapter on Evaluation of Female SUI
